相互作用
Baricitinib + Idecabtagene vicleucel
重症度: 重大
Baricitinib and Idecabtagene vicleucel: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Baricitinib may blunt the expansion and activity of CAR T cells, potentially reducing efficacy. Its immunosuppression also adds to the infection risk that already follows lymphodepletion and CAR T therapy.
この相互作用をわかりやすく説明すると
Baricitinib and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Baricitinib belongs to Musculoskeletal; Idecabtagene vicleucel belongs to Oncology.
なぜ起こるのか
JAK inhibition suppresses T-cell and cytokine signaling, impairing CAR T-cell function and adding to immunosuppression.
対処法
Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. If it is needed, coordinate with the treating oncology team and monitor for infection.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、BaricitinibとIdecabtagene vicleucelの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Baricitinibのその他の相互作用
Idecabtagene vicleucelのその他の相互作用
よくある質問
Can I take Baricitinib with Idecabtagene vicleucel?
MediHelp rates the interaction as major. Baricitinib and Idecabtagene vicleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Baricitinib may blunt the expansion and activity of CAR T cells, potentially reducing efficacy. Its immunosuppression also adds to the infection risk that already follows lymphodepletion and CAR T therapy.
How serious is the interaction between Baricitinib and Idecabtagene vicleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid baricitinib around leukapheresis and CAR T infusion unless clearly needed. If it is needed, coordinate with the treating oncology team and monitor for infection.
What other medicines interact with Baricitinib?
MediHelp also lists interactions of Baricitinib with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Tofacitinib. The full list is on the Baricitinib page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
